Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-014418)

Filing Details

Accession Number:: 0001209191-17-014418
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-02-24 17:07:16
Reporting Period:: 2017-02-22

Filing Date:: 2017-02-24
Accepted Time:: 2017-02-24 17:07:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1403708	Evoke Pharma Inc	EVOK	In Vitro & In Vivo Diagnostic Substances (2835)	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1065168	J Kenneth Widder	C/O Evoke Pharma, Inc. 420 Stevens Avenue, Suite 370 Solana Beach CA 92075		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-02-22	418,605	$2.90	1,472,867	No	4	P	Indirect	Directly owned by LVP III
Common Stock	Acquisiton	2017-02-22	20,930	$2.90	73,641	No	4	P	Indirect	Directly owned by Associates
Common Stock	Acquisiton	2017-02-22	10,465	$2.90	36,821	No	4	P	Indirect	Directly owned by Partners

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Directly owned by LVP III
No	4	P	Indirect	Directly owned by Associates
No	4	P	Indirect	Directly owned by Partners

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,250	Indirect	Directly owned by LVPMC

Footnotes

The reported securities are owned directly by each of LVPMC, LLC ("LVPMC"), LVP Life Science Ventures III, L.P. ("LVP III"), LVP III Associates, L.P. ("Associates") and LVP III Partners, L.P. ("Partners"). LVP GP III, LLC ("GP III") is the general partner of LVP III, Associates and Partners. The reporting person disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein.